Muslims worldwide celebrate Eid al-FitrSociety & Culture June 25, 5:18
Mexico knocks out Russia from FIFA Confederations Cup with 2-1 win in KazanSport June 24, 19:59
Putin visits Crimean youth camp ArtekSociety & Culture June 24, 19:42
Conflict around Qatar should be settled by diplomatic means - source at Foreign MinistryRussian Politics & Diplomacy June 24, 16:44
More than 237,000 fans attend Confederations Cup matches already - Deputy PM MutkoSport June 24, 15:03
Sistema's president hopes for dialogue with Rosneft on settlement agreementBusiness & Economy June 24, 14:56
CNN deletes article about meeting between Scaramucci and Russian Direct Investment FundWorld June 24, 13:12
Ukrainian Army units shell Donetsk Republic in first hours of newceasefireWorld June 24, 5:19
Politician says Russia vs Mexico football game will be interesting to watchSport June 23, 21:11
MOSCOW, February 19. /TASS/. Russia’s Federal Antimonopoly Service (FAS) wants to introduce obligatory licensing of medicines to combat HIV in Russia to make them more affordable for the population, Lesya Davydova, head of the international economic department of the FAS said on Friday.
Currently, the prices for such medicines are quite high in Russia, which makes the medical treatment unaffordable for a large number of people. At the same time most of the anti-virus medicines are produced abroad and don’t have Russian analogues, she said.
Davydova said that in South Africa after the compulsory licensing of certain drugs (in particular those fighting HIV) the cost of treatment reduced tenfold.
"So here we also see a lot of work we could do,"- she said.
In October 2015, representatives of 19 non-profit organizations to combat HIV appealed to Prime Minister Dmitry Medvedev to introduce compulsory licensing of antiretroviral drugs for the treatment of this disease.
In early February, the founder of the Pharmasyntez pharmaceutical company Vikram Puniya addressed to Russian President Vladimir Putin with a proposal to apply the mechanism of forced licensing of hepatitis drugs. Puniya also referred to the experience of the BRICS countries in this field. Putin promised to analyze the legal side of the case, and if such practice exists in other countries, to consider the proposal.